For a printer-friendly version of abstracts to all Tissue of Origin related publications and posters, click here.
Peer-reviewed publications
Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin, FA Monzon, TJ Koen. Arch Pathol Lab Med 2010 Feb; 134 (2):216-24.
Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test, FA Monzon, F Madeiros, M Lyons-Weiler, WD Henner, Diagn Pathol. 2010 Jan 13;5:3
Diagnosis of uncertain primary tumors with the Pathwork® tissue-of-origin test, FA Monzon, CI Dumur, Expert Review of Molecular Diagnostics, January 2010, Vol. 10, No. 1, Pages 17-25
Determining Tissue of Origin for Metastatic Cancers; Meta-Analysis and Literature Review of Immunohistochemistry Performance, GG Anderson, L Weiss. Applied Immunohistochemistry & Molecular Morphology: January 2010 - Volume 18 - Issue 1 - pp 3-8
Multicenter Validation of a 1,550-Gene Expression Profile for Identification of Tumor Tissue of Origin. FA Monzon, M Lyons-Weiler, LJ Buturovic, CT Rigl, WD Henner, C Sciulli, CI Dumur, F Medeiros, GG Anderson. J Clin Oncol. 2009;27:1-13; doi:10.1200/JCO.2008.17.9762.
Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers. CI Dumur, M Lyons-Weiler, C Sciulli, CT Garrett, I Schrijver, TK Holley, J Rodriguez-Paris, JR Pollack, JL Zehnder, M Price, JM Hagenkord, CT Rigl, LJ Buturovic, GG Anderson, FA Monzon. J Mol Diagn. 2008;10(1):67-77.
Abstracts & Posters
Impact of a Gene Expression-Based Tissue of Origin Test on Diagnosis and Recommendations for First-Line Chemotherapy, M. Laouri, J.S. Nystrom, M. Halks-Miller, W.D. Henner. Poster presented at ASCO, June 4 - 8, 2010, Chicago, IL
Microarray-Based Gene Expression Assay for Identification of Primary Site Using Formalin-Fixed Paraffin-Embedded (FFPE) Tissue, R. Pillai, R. Deeter, L. Buturovic, J.S. Nystrom, M. Halks-Miller, D. Henner. Poster presented at ASCO GI, January 22 - 24, 2010, Orlando, FL
Gene Expression Profiles Help Identify the Tissue of Origin for Metastatic Brain Cancers, AHB Wu, JC Drees, HP Wang, SB VandenBerg, A Lal, WD Henner, R Pillai. Poster presented at AMP, November 19 - 22, 2009, Kissimmee, FL
Microarray-Based Gene Expression Test as an Aid to Tumor Diagnosis Using Formalin-Fixed Paraffin-Embedded (FFPE) Specimens, R. Pillai, R. Deeter, C.T. Rigl, M. Halks-Miller, L. Buturovic, D. Henner; Pathwork Diagnostics. Poster presented at CAP, October 11 - 14, 2009, Washington, D.C.
Validation of a microarray-based gene expression test for tumors with uncertain origins using formalin-fixed paraffin-embedded (FFPE) specimens. R. Pillai, R. Deeter, C.T. Rigl, M.Halks-miller, W.D Henner, L.Buturovic; Pathwork Diagnostics. J Clin Oncol. 2009;27 (suppl; abstr e20015).
Use of a microarray-based 1550-gene expression profile in the diagnosis of carcinoma of unknown primary (CUP). Monzon FA, Medeiros F , Henner W. Poster presented at ASCO 2009 Gastrointestinal Cancers Symposium; January 15-17, 2009; San Francisco CA.
A meta-analysis of the use of IHC testing in metastatic disease: the need for integration of new technologies. GG Anderson, LM Weiss. Poster presented at the ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer; Oct 30 - Nov 1, 2008; Hollywood, FL.
Assessing the impact of tumor devitalization time on gene expression-based tissue of origin testing. CI Dumur, A Ladd, A Ferreira-Gonzalez, CT Rigl, RA Deeter, DS Wilkinson, CN Powers, CT Garrett. Poster presented at the Association for Molecular Pathology; October 29 - November 2, 2008; Grapevine, TX.
Gene expression microarray-based diagnostic test may identify primary tumor site in patients with carcinoma of unknown primary (CUP). F Medeiros, et al. Poster presented at the Association for Molecular Pathology; October 29 - November 2, 2008; Grapevine, TX.
Clinical verification of the Pathwork Tissue of Origin Test on poorly differentiated metastases. CI Dumur, et al. Poster presented at the Association for Molecular Pathology; October 29 - November 2, 2008; Grapevine, TX.
Ovarian mucinous neoplasms: Can gene expression microarray-based technology distinguish primary versus metastatic tumors? F Medeiros, KC Halling, CP Kolbert, F Rakhshan Rohakhtar, TM Kane Lindgren, MJ Wilson, CM Rendler, MP Goetz, DA Bell.
Poster presented at the International Congress of the International Academy of Pathology; October 12 - 17, 2008; Athens, Greece.
A gene expression microarray-based diagnostic test applied to patients with carcinoma of unknown primary (CUP). F Medeiros, CP Kolbert, F Rakshan Rohakhtar, T Kane Lindgren, MJ Wilson, CT Rigl, MP Goetz, WD Henner, KC Halling. American Society of Clinical Oncology; May 30-June 3, 2008; Chicago, IL; Abstract 22123.
Validation of a gene expression-based tissue of origin test applied to poorly differentiated and undifferentiated cancers. FA Monzon, CI Dumur, M Lyons-Weiler, CM Sciulli, CT Garrett, JM Hagenkord, L Buturovic, R Deeter, SH Becker, CT Rigl, GG Anderson. Poster presented at the annual meeting for the Association for Molecular Pathology; November 7-10, 2007; Los Angeles, CA; Abstract #ST02.
Analytical performance of a microarray-based expression test to determine tissue of origin in uncertain primary cancers. CI Dumur, M Lyons-Weiler, CT Garrett, TK Holley, I Schrijver, J Rodriguez-Paris, JR Pollack, JL Zehnder, CM Sciulli, JM Hagenkord, M Price, CT Rigl, LJ Buturovic, GG Anderson, FA Monzon. Poster presented at the annual meeting of the Association for Molecular Pathology; November 7-10, 2007; Los Angeles, CA; Abstract #ST01.
A gene expression-based assay for identifying tissue of origin: application to metastatic lesions in the brain. S Cheshier, S Chang, L Buturovic, CT Rigl, WD Henner, GG Anderson. Poster presented at the annual meeting of the Society for Neuro-Oncology, November 15-18, 2007; Dallas, TX; Abstract GE-15.
On the optimal number of gene expression mMarkers for tissue of origin cancer diagnostics. LJ Buturovic. Poster presented at the annual meeting for the American Association for Cancer Research; September 17-20, 2007; Atlanta, GA; B4.
Incidence, costs of care and survival of medicare beneficiaries diagnosed with carcinoma of unknown primary origin. KB Tong, HB Hubert, B Santry, AJ Layton, SH Becker, GG Anderson. Poster presented at the annual meeting of the American Society of Clinical Oncology; June 2-6, 2006; Atlanta, GA. Abstract.